Wall Street falls as trade hopes wane
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/16/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- SanDisk upgraded at JPMorgan after investor day; shares climb
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
Apple (AAPL) Opens Lower as Tech Pressured, Down 2.75%
December 3, 2019 9:31 AM ESTApple (NASDAQ: AAPL) Opens Lower as Tech Pressured, Down 2.75%
... MoreH.C. Wainwright Downgrades Audentes Therapeutics (BOLD) to Neutral Following Acquisition
December 3, 2019 7:15 AM ESTH.C. Wainwright analyst Debjit Chattopadhyay downgraded Audentes Therapeutics (NASDAQ: BOLD) from Buy to Neutral.
For an analyst ratings summary and ratings history on Audentes Therapeutics click here. For more ratings news on Audentes Therapeutics click here.
Shares of Audentes Therapeutics closed at $28.61 yesterday.
... MoreMizuho Securities Downgrades Audentes Therapeutics (BOLD) to Neutral Following Acquisition
December 3, 2019 6:53 AM ESTMizuho Securities analyst Difei Yang downgraded Audentes Therapeutics (NASDAQ: BOLD) from Buy to Neutral with a price target of $60.00.
For an analyst ratings summary and ratings history on Audentes Therapeutics click here. For more ratings news on Audentes Therapeutics click here.
Shares of Audentes Therapeutics closed at $28.61 yesterday.
... More